1)Lp-PLA2脂蛋白磷脂酶A2
1.Objective:To investigate the expression of Lp-PLA2 and LPA in rabbit\'s cerebral ischemia and their correlationship.目的:研究大鼠脑缺血损伤后,脂蛋白磷脂酶A2(Lp-PLA2)与溶血磷脂酸(LPA)的表达及相互关系。
2)lipoprotein-associated phospholipase A2脂蛋白相关磷脂酶A2
1.Correlation Between Carotid Atherosclerosis and Lipoprotein-Associated Phospholipase A2颈动脉粥样硬化与脂蛋白相关磷脂酶A2的相关性
2.Objective: To establish a LC-MS/MS method for determining the concentration of platelet activating factor(PAF) in human plasma and to know the activity of lipoprotein-associated phospholipase A2(LP-PLA2),an independent risk factor for coronary artery disease(CAD) in clinical practice.目的:建立一种人血浆中血小板活化因子(PAF)的液相色谱-串联质谱测定方法(LC-MS/MS),从而反映临床冠心病独立风险预测因子脂蛋白相关磷脂酶A2(LP-PLA2)活性。
英文短句/例句
1.Expression Vector Construction of Lipoprotein Associated Phospholipase A2脂蛋白相关磷脂酶A2表达载体的构建
2.Carotid Atherosclerosis Relevant Clinical Research in Lipoprotein-associated Phospholipase A2 and Tongue Presentations颈动脉粥样硬化与脂蛋白相关磷脂酶A2及舌象的相关临床研究
3.Correlation Between Carotid Atherosclerosis and Lipoprotein-Associated Phospholipase A2颈动脉粥样硬化与脂蛋白相关磷脂酶A2的相关性
4.Relationship between lipoprotein-associated phospholipase A2 concentration and arteriosclerosis in rabbits脂蛋白相关磷脂酶A2浓度与兔动脉粥样硬化关系的研究
5.Connecting Research to LP-PLA2 Gene Polymorphisms R92H and A379V of the Patients with Coronary Heart Disease冠心病患者脂蛋白相关磷脂酶A2基因R92H和A379V基因多态性研究
6.Lipoprotein-associated Phospholipase A2: Its Association with Coronary Artery Disease and Relationship with Lipids and Inflammation Biomarkers;脂蛋白相关磷脂酶A2与冠心病的关系及其与血脂、炎症标志物的相关性研究
7.Study on the Relationships between Lipoprotein-Associated Phospholipasea2 and High Sensitivity C-Reactive Protein with Atherosclerosis Plaque Stableness脂蛋白相关磷脂酶A2及超敏C反应蛋白与动脉粥样硬化斑块稳定性的研究
8.The Relevance between Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease and Its Changes after Percutaneous Coronary Intervention;脂蛋白相关磷脂酶A2与冠心病的相关性及经皮冠状动脉介入术后的变化
9.The Relationship between Lipoprotein-associated Phospholipase a 2 Concentration and Atherosclerasis in Rabbits and the Influence of Simvastatin to Lipoprotein-associated Phospholipase A 2 Concentration脂蛋白相关磷脂酶A2浓度与兔动脉粥样硬化的关系以及辛伐他汀干预作用的研究
10.Relationship between Plasma Lipoprotein-Associated Phospholipase A_2 Activity and Coronary Heart Disease;脂蛋白相关性磷脂酶A_2活性与冠心病
11.The Study on the Relationship between sPLA2、hs-CRP and Coronary Pathological Changes and Clinical Significance;分泌型磷脂酶A2、高敏C反应蛋白与冠状动脉病变相关性研究及其临床意义
12.Relationship Between Coronary Atherosclerotic Plaque and Secretory Type Ⅱ Phospholipase A2,Hypersensitive C-Reactive Protein冠状动脉粥样硬化斑块性质与分泌型磷脂酶A2、高敏C反应蛋白的相关性
13.Expression of GroupⅤand GroupⅩSecretory Phospholipase A2 on RAW264.7 Cell Induced by Oxidized Low Density Lipoprotein氧化型低密度脂蛋白诱导RAW264.7细胞表达V型和X型分泌型磷脂酶A2
14.Calphobindin Annexin A2 and Tumorigenesis as well as Development钙磷脂结合蛋白annexin A2与肿瘤发生发展
15.The Change of Secretory Type Ⅱ Phospholipase A2 in Acute Coronary Syndrome and the Relationship with CRP;急性冠脉综合症患者分泌型磷脂酶A2的变化及其与C反应蛋白的关系
16.The Measurement of Lp-PLA_2 and Its Significance in Patients with Coronary Heart Disease;冠心病患者脂蛋白相关磷脂酶A_2的测定及临床意义
17.The Characteristics of Lipoprotein-associated Phospholipase A_2 Activity in the Non-insulin-dependent Diabetes Mellitus2型糖尿病患者脂蛋白相关磷脂酶A_2活性变化特征
18.Expression of Lp-PLA2 and LPA in Rabbit's Cerebral Ischemia and Their Correlationship磷脂酶A2与溶血磷脂酸在大鼠脑缺血性损伤后的表达及相互关系研究
相关短句/例句
lipoprotein-associated phospholipase A2脂蛋白相关磷脂酶A2
1.Correlation Between Carotid Atherosclerosis and Lipoprotein-Associated Phospholipase A2颈动脉粥样硬化与脂蛋白相关磷脂酶A2的相关性
2.Objective: To establish a LC-MS/MS method for determining the concentration of platelet activating factor(PAF) in human plasma and to know the activity of lipoprotein-associated phospholipase A2(LP-PLA2),an independent risk factor for coronary artery disease(CAD) in clinical practice.目的:建立一种人血浆中血小板活化因子(PAF)的液相色谱-串联质谱测定方法(LC-MS/MS),从而反映临床冠心病独立风险预测因子脂蛋白相关磷脂酶A2(LP-PLA2)活性。
3)lipoprotein-associated phospholipase A2脂蛋白相关性磷脂酶A2
4)phospholipase A2磷脂酶A2
1.Detection and Clinical Significance of Phospholipase A2 in Semen of Male Infertile Patients;男性不育病人精液中磷脂酶A2的测定及其临床意义
2.Construction and Identification for Cell Strain of Anti-human Seminal Plasma Phospholipase A2 Monoclonal Antibody;抗人精浆磷脂酶A2单克隆抗体细胞株的建立与鉴定
3.The Study of Phospholipase A2 Activity in Cerebrospinal Fluid of Intracranial in Fected Patients;颅内感染患者脑脊液中磷脂酶A2活性的研究
5)phospholipase A_2磷脂酶A2
1.The phospholipase, phospholipase A_2 activity and meat quality traits from normal pork and PSE pork were determined.宰后PSE肉的pH1h和pH24h低于正常肉,而L值(宰后1h、24h)、脂肪氧化程度、汁液流失率、贮藏损失、蒸煮损失和磷脂酶A2总活性明显高于正常肉。
2.The hydrolysis of lecithin by phospholipase A_2 was firstly studied in vesicle solution and the influence of relevant parameters was investigated. 首次在泡囊水溶液中研究磷脂酶A2 催化水解卵磷脂并考察了各种因素对该反应的影响。
3.Objective: To improve a method for the determination of the phospholipase A_2 activity,the effects of glycyrrhizin and platycodin on phospholipase A_2 activity in vitro are observed.目的:建立一种体外磷脂酶A2活性测定的方法,并观察甘草总皂苷、桔梗总皂苷体外对磷脂酶A2活性的影响。
6)phospholipase A 2磷脂酶A2
1.To attain the optimal technological conditions of enzymic by drolysis of soybean phospholipid,the concentrated soybean phospholipid was selected as substrate, the phospholipase A 2 as the hydrolysis tool enzyme,and the enzyme-modified phospholipid was studied by the means of quiescence reaction.为获取制备酶水解磷脂的最佳条件 ,以浓缩磷脂为底物 ,磷脂酶A2 为水解酶 ,采用静止反应方式 ,进行了大豆磷脂酶水解改性研究。
2.objective: To study the pathogenesis of acute lung injury (ALI) of rabbits induced by intravascular injection of endotoxin (ET), as well as the role of the activation of phospholipase A 2(PLA 2).目的 :研究大肠杆菌内毒素致兔急性肺损伤 (ALI)发病机制及磷脂酶A2 (PLA2 )激活在此病理生理过程中的致伤机制。
3.Objective: To investigate the changes of levels of tumour necrosis α(TNF α), prostaglandin E 2 (PGE 2 ), and phospholipase A 2(PLA 2)in cerebrospinal fluid of patients with tuberculous meningitis and their clinical significances.目的 :探讨肿瘤坏死因子 α(TNF α) ,磷脂酶A2 (PLA2 ) ,前列腺素E2 (PGE2 )在结核性脑膜炎患者脑脊液中的变化及临床意义。
延伸阅读
结晶胰蛋白酶 ,胰蛋白酶药物名称：结晶胰蛋白酶英文名：Trypsin别名： 结晶胰蛋白酶 ,胰蛋白酶外文名：Trypsin 适应症： 1.用于脓胸、血胸、外科炎症、溃疡、创伤性损伤、娄管等所产生的局部水肿、血肿、脓肿。 2.用于呼吸道疾病。 3.用于治疗毒蛇咬伤，曾试用于竹叶青、银环蛇、眼镜蛇、蝮蛇等毒蛇咬伤的各型病人８００余例，均获治愈。 用量用法： 1.一般应用：１次５０００单位，每日１次肌注，用量酌情而定。为防止疼痛，可加适量普鲁卡因。局部用药视情而定，可配成溶液制剂（ｐＨ７．４～８．２，微碱性时活性最强）、喷雾剂、粉剂、油膏等，用作体腔内注射、患部注射、喷雾、湿敷、涂搽等。 2.治蛇毒：取注射用结晶胰蛋白酶２０００单位１～３支，加０．２５％～０．５％盐酸普鲁卡因（或注射用水）４～２０ｍｌ稀释，以牙痕为中心，在伤口周围作浸润注射，或在肿胀部位上方作环状封闭１～２次。如病情需要可重复使用。若伤肢肿胀明显，可于注射本品３０分钟后，切开伤口排毒减压（严重出血者例外），也可在肿胀部位针刺排毒。如伤口已坏死、溃烂，可用其０．１％溶液湿敷患处 注意事项： 1.较常见的不良反应有寒战、发热、头痛、头晕、胸痛、腹痛等，但并不影响继续用药，一般给予抗组胺药和解热药，即可控制或预防。 2.不可用于急性炎症及出血空腔中。 3.肝肾损伤、血液凝固异常和有出血倾向的病人忌用。 4.吸取注射液后应另换针头，以免注射时疼痛。 5.不可作静注。用前需作划痕试验，应注意可能产生过敏反应。 6.外用时，可采用注射用制剂以缓冲液溶解，但必须在３小时内用毕。 规格： 注射用结晶胰蛋白酶：每支１０００单位、２０００单位、５０００单位、１００００单位.类别：酶类及生化药物
